{"entity":{"type":"insider","cik":"0001717580","url":"/insider/0001717580","json_url":"/insider/0001717580.json","name":"Palczuk Linda","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2018-08-15","last":"2025-01-22","span_basis":"filed_date"},"name_variants":[{"name":"Palczuk Linda","source":"filing","n_filings":10,"first_seen":"2018-08-15","last_seen":"2025-01-22"}],"transactions":[{"id":5161901,"accession":"0001104659-25-005248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-005248","line_url":"/filing/0001104659-25-005248#line-1","is_derivative":false,"issuer_cik":"0001012477","issuer_name":"AVADEL PHARMACEUTICALS PLC","issuer_ticker":"AVDL","issuer_name_source":null,"issuer_url":"/issuer/0001012477","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.928,"price_display":"7.93","price_state":"stated","total_value":39640.0,"total_display":"39,640.00","total_whole":"39,640","shares_owned_after":67900.0,"shares_owned_after_display":"67,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-21","filed_date":"2025-01-22","scope":"insider"},{"id":2462282,"accession":"0001104659-24-126999","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-126999","line_url":"/filing/0001104659-24-126999#line-1","is_derivative":false,"issuer_cik":"0001012477","issuer_name":"AVADEL PHARMACEUTICALS PLC","issuer_ticker":"AVDL","issuer_name_source":null,"issuer_url":"/issuer/0001012477","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":10.1892,"price_display":"10.19","price_state":"stated","total_value":30567.6,"total_display":"30,567.60","total_whole":"30,568","shares_owned_after":66400.0,"shares_owned_after_display":"66,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-06","filed_date":"2024-12-10","scope":"insider"},{"id":8726199,"accession":"0001104659-23-058439","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-058439","line_url":"/filing/0001104659-23-058439#line-1","is_derivative":false,"issuer_cik":"0001012477","issuer_name":"AVADEL PHARMACEUTICALS PLC","issuer_ticker":"AVDL","issuer_name_source":null,"issuer_url":"/issuer/0001012477","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"ADSs","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":14.76,"price_display":"14.76","price_state":"stated","total_value":36900.0,"total_display":"36,900.00","total_whole":"36,900","shares_owned_after":52400.0,"shares_owned_after_display":"52,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-09","filed_date":"2023-05-10","scope":"insider"},{"id":6215211,"accession":"0001104659-22-130515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-130515","line_url":"/filing/0001104659-22-130515#line-1","is_derivative":false,"issuer_cik":"0001012477","issuer_name":"AVADEL PHARMACEUTICALS PLC","issuer_ticker":"AVDL","issuer_name_source":null,"issuer_url":"/issuer/0001012477","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"ADSs","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":7.2025,"price_display":"7.20","price_state":"stated","total_value":14405.0,"total_display":"14,405.00","total_whole":"14,405","shares_owned_after":49900.0,"shares_owned_after_display":"49,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-23","filed_date":"2022-12-28","scope":"insider"},{"id":6358366,"accession":"0001104659-22-066227","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-066227","line_url":"/filing/0001104659-22-066227#line-1","is_derivative":false,"issuer_cik":"0001012477","issuer_name":"AVADEL PHARMACEUTICALS PLC","issuer_ticker":"AVDL","issuer_name_source":null,"issuer_url":"/issuer/0001012477","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"ADSs","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.6,"price_display":"1.60","price_state":"stated","total_value":16000.0,"total_display":"16,000.00","total_whole":"16,000","shares_owned_after":47900.0,"shares_owned_after_display":"47,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":2870429,"accession":"0001179110-20-009084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009084","line_url":"/filing/0001179110-20-009084#line-1","is_derivative":false,"issuer_cik":"0001012477","issuer_name":"AVADEL PHARMACEUTICALS PLC","issuer_ticker":"AVDL","issuer_name_source":null,"issuer_url":"/issuer/0001012477","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"ADS","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":7.9399,"price_display":"7.94","price_state":"stated","total_value":19849.75,"total_display":"19,849.75","total_whole":"19,850","shares_owned_after":37900.0,"shares_owned_after_display":"37,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-17","scope":"insider"},{"id":8637306,"accession":"0001104659-19-070213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-19-070213","line_url":"/filing/0001104659-19-070213#line-1","is_derivative":false,"issuer_cik":"0001012477","issuer_name":"AVADEL PHARMACEUTICALS PLC","issuer_ticker":"AVDL","issuer_name_source":null,"issuer_url":"/issuer/0001012477","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"ADSs","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":5.91,"price_display":"5.91","price_state":"stated","total_value":44325.0,"total_display":"44,325.00","total_whole":"44,325","shares_owned_after":35400.0,"shares_owned_after_display":"35,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-05","scope":"insider"},{"id":8116861,"accession":"0001209191-19-004240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-004240","line_url":"/filing/0001209191-19-004240#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":10.53,"price_display":"10.53","price_state":"stated","total_value":31590.0,"total_display":"31,590.00","total_whole":"31,590","shares_owned_after":8500.0,"shares_owned_after_display":"8,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-16","filed_date":"2019-01-17","scope":"insider"},{"id":6559925,"accession":"0001209191-18-051471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-051471","line_url":"/filing/0001209191-18-051471#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":16.52,"price_display":"16.52","price_state":"stated","total_value":41300.0,"total_display":"41,300.00","total_whole":"41,300","shares_owned_after":5500.0,"shares_owned_after_display":"5,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-18","scope":"insider"},{"id":6396476,"accession":"0001209191-18-046827","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-046827","line_url":"/filing/0001209191-18-046827#line-1","is_derivative":false,"issuer_cik":"0001660334","issuer_name":"Verrica Pharmaceuticals Inc.","issuer_ticker":"VRCA","issuer_name_source":null,"issuer_url":"/issuer/0001660334","owner_cik":"0001717580","owner_name":"Palczuk Linda","owner_display_name":"Palczuk Linda","owner_url":"/insider/0001717580","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":45000.0,"total_display":"45,000.00","total_whole":"45,000","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-19","filed_date":"2018-08-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001012477","name":"AVADEL PHARMACEUTICALS PLC","url":"/issuer/0001012477","role":"Director","n_filings":7,"first_seen":"2019-12-05","last_seen":"2025-01-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001660334","name":"Verrica Pharmaceuticals Inc.","url":"/issuer/0001660334","role":"Officer (Chief Operating Officer)","n_filings":3,"first_seen":"2018-08-15","last_seen":"2019-01-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001717580","retrieved_at":"2026-08-22T07:28:36+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}